Le Lézard
Classified in: Health
Subjects: PER, WOM, DEI

CCRM FERTILITY ANNOUNCES CHELSEY LEISINGER AS NEW VP OF NETWORK LAB COMPLIANCE


Dr. Leisinger joins CCRM's leading team of fertility specialists, focusing on laboratory compliance

LONE TREE, Colo., Jan. 22, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today the appointment of Chelsey Leisinger, MS, PhD, HCLD/CC as VP of Network Lab Compliance.

As the newly appointed Vice President of Network Lab Compliance for CCRM, Dr. Leisinger, a renowned fertility specialist, will play a pivotal role in supervising select laboratory locations. Collaborating closely with fellow lab directors and key members of the corporate lab leadership, Dr. Leisinger's expertise will be instrumental in leveraging CCRM's cutting-edge proprietary technology and innovative scientific techniques within the fertility arena. Her primary focus will be on ensuring laboratory compliance and risk mitigation, thereby elevating the fertility experience for both CCRM laboratory technologists and patients.

"I am thrilled to join the CCRM Fertility expert team to help further the mission of providing top-notch fertility care," said Dr. Leisinger. "Ensuring IVF laboratories are functioning to the best of their abilities and exceeding compliance standards is a passion of mine."

Dr. Leisinger completed her Bachelor of Science degree at Iowa State University, where she discovered her interest in animal reproduction and embryology. She later went on to earn a Master of Science degree at the Ohio State University College of Veterinary Medicine, where she fine-tuned her skills in bovine, equine and camelid embryology.

After developing an avid interest in human IVF, Dr. Leisinger shifted focus, pursuing a PhD in Biomedical and Veterinary Medical Sciences with a focus on reproductive physiology at Louisiana State University School of Veterinary Medicine. During this time, she assisted with batch IVF cycles at a high-volume Seattle fertility center as a consulting senior embryologist.

In 2017, Dr. Leisinger joined Ovation® Fertility as a senior embryologist and laboratory manager. She transitioned to laboratory director after obtaining her certification as a High-complexity Clinical Laboratory Director (HCLD).

Most recently, Dr. Leisinger served as an off-site laboratory director for four of Ovation® Fertility's laboratories across 3 states (Louisiana, Michigan, and Ohio).

About CCRM?Fertility
CCRM Fertility is a global pioneer in fertility treatment, research, and science. Founded by Dr.?William Schoolcraft?more than 35 years ago, CCRM Fertility specializes in the most advanced fertility treatments, with deep expertise in IVF, fertility testing, egg freezing, preimplantation genetic testing, third party reproduction and egg donation. CCRM?Fertility?leverages its own data and a dedicated team of in-house reproductive endocrinologists, embryologists, and geneticists to deliver industry-leading outcomes. CCRM Fertility is a proud strategic partner of Unified Women's Healthcare, which is accelerating meaningful change in women's healthcare by building healthy, innovative, and mission-driven businesses to meet the comprehensive needs of women across the entirety of their health journey. For more information, visit?www.ccrmivf.com.

SOURCE CCRM Fertility


These press releases may also interest you

at 22:05
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

at 22:00
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

at 21:27
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

at 20:40
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...

at 20:37
Mexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B. de C.V. (B.M.V.: LABB) regarding its agreement to redeem capital in Marzam. The...

at 20:35
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES The updated release reads: ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9 NOT FOR...



News published on and distributed by: